DPPIV, MMP-8, MMP-9, and MMP-13 levels decreased across COVID-19 variants, suggesting a reduced proteolytic and inflammatory response, consistent with Omicron’s lower severity compared to Alpha (46). This evidence concerns the gene MMP13 and COVID-19.